In one 
                    of the studies, published in the March issue of Nature 
                    Neuroscience, researchers examined DISC1's role in forming 
                    connections between nerve cells. Numerous studies have suggested 
                    that schizophrenia results from abnormal connectivity. The 
                    fact that symptoms typically arise soon after adolescence, 
                    a time of massive reorganization of connections between nerve 
                    cells, supports this idea.
                  The scientists 
                    began their study by surveying rat nerve cells to see where 
                    DISC1 was most active. Unsurprisingly, they found the highest 
                    DISC1 activity in connections between nerve cells. To determine 
                    what DISC1 was doing in this location, the researchers used 
                    a technique called RNA interference to partially shut off 
                    DISC1 activity. Consequently, they saw a transient increase 
                    and eventual reduction in size and number of dendritic spines, 
                    spikes on nerve cells' branch-like extensions that receive 
                    input from other nerve cells.
                  To determine 
                    how DISC1 regulates dendritic spine formation, the researchers 
                    studied which brain proteins interact with the protein expressed 
                    by the DISC1 gene. They identified one, called Kal-7, which 
                    earlier studies suggested is critical for proper dendritic 
                    spine formation. Further experiments suggested that the DISC1 
                    protein acts as temporary holding place for Kal-7, binding 
                    it until it can be released to trigger a molecular cascade 
                    that results in dendritic spine formation.
                  Study 
                    leader Akira Sawa, M.D., Ph.D., professor of psychiatry and 
                    director of the program in molecular psychiatry at the Johns 
                    Hopkins University School of Medicine, says it is becoming 
                    clear that having a defective DISC1 gene might lead to an 
                    abnormally small number and size of dendritic spines, which 
                    could lead nerve cells to maintain weaker connections with 
                    unusually low numbers of neighboring neurons. Such abnormal 
                    connectivity has long been seen in autopsied brains from schizophrenia 
                    patients. 
                  "Connections 
                    between neurons are constantly being made and broken throughout 
                    life, with a massive amount of broken connections, or 'pruning,' 
                    happening in adolescence," Sawa says. "If this pruning doesn't 
                    happen correctly, it may be one reason for the pathogenesis 
                    of schizophrenia," he adds.
                  In the 
                    second study, published in the Feb. 25 issue of Neuron, 
                    Sawa's team generated a new animal model of schizophrenia 
                    by temporarily shutting off the DISC1 gene in mice in the 
                    prefrontal cortex, a brain area known to differ in schizophrenic 
                    people. The new model allowed them to study other roles for 
                    DISC1 in the brain.
                  The researchers 
                    created their novel model by, again, using RNA interference. 
                    They injected short pieces of the nucleic acid RNA engineered 
                    to shut off the DISC1 gene into cavities in the developing 
                    brains of mouse fetuses two weeks after conception. Tests 
                    showed that these snippets of RNA migrated into cells in the 
                    prefrontal cortex, part of the brain located near the forehead. 
                    
                  This shutoff 
                    was temporary, with the gene's function fully restored within 
                    three weeks, or about a couple of weeks after birth. At various 
                    times after the gene was reactivated, the scientists examined 
                    the animals' brains and behavior, looking for differences 
                    from normal mice.
                  Sawa's 
                    team found that in the DISC1 shutoff group, nerve cells in 
                    the prefrontal cortex that produce dopamine, one of the chemical 
                    signals that nerve cells use to communicate, were markedly 
                    immature as the animals entered adolescence. Furthermore, 
                    the animals showed signs of a deficit of interneurons, nerve 
                    cells that connect other neurons in neural pathways.
                  They also 
                    found several behavioral differences between these mice compared 
                    to normal mice as the animals entered adolescence. For example, 
                    those in the shutoff group reacted more strongly to stimulants, 
                    displaying more locomotion than normal mice. Interestingly, 
                    these effects were somewhat mitigated when the researchers 
                    gave the animals clozapine, a drug used to treat schizophrenia.
                  Taken 
                    together, Sawa says, results of both studies suggest that 
                    these anatomical differences, which seem to be influenced 
                    by the DISC1 gene, cause problems that start before birth 
                    but surface only in young adulthood.
                  "If we 
                    can learn more about the cascade of events that lead to these 
                    anatomical differences, we may eventually be able to alter 
                    the course of schizophrenia. During adolescence, we may be 
                    able to intervene to prevent or lessen symptoms," Sawa says.
                   
                  
---
                  
                  Other 
                    Johns Hopkins researchers who participated in the Nature 
                    Neuroscience study include Akiko Hayashi-Takagi, Manabu 
                    Takaki, Saurav Seshadri, Yuichi Makino, Anupamaa J. Seshadri, 
                    Koko Ishizuka, Jay M. Baraban, and Atsushi Kamiya. Other Johns 
                    Hopkins researchers who participated in the Neuron study 
                    include Minae Niwa, Atsushi Kamiya, Hanna Jaaro-Peled, Saurav 
                    Seshadri, Hideki Hiyama, and Beverly Huang.
                  Contact: 
                    Christen Brownlee
                    cbrownlee@jhmi.edu
                    410-955-7832
                    Johns Hopkins Medical 
                    Institutions 
                  For more 
                    information, go to: 
                    http://neuroscience.jhu.edu/AkiraSawa.php 
                    
                    http://www.hopkinsmedicine.org/psychiatry/research/sawalab/
                  Article 
                    via Eurekalert.com